NICHOLE BROWN: Open Payments
NPI 1225364227 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 34 payments from 10 companies in 2025. Trend: 2023 $355 · 2024 $78 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $118 |
| Orexo US, Inc. | 6 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $104 |
| Corium, LLC | 4 | $85 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $75 |
| Valinor Pharma, LLC | 3 | $63 |
| PROTEGA PHARMACEUTIALS INC | 1 | $42 |
| ABBVIE INC. | 2 | $34 |
| Lundbeck LLC | 1 | $20 |
| Boston Scientific Corporation | 1 | $16 |
Products named: XTAMPZA, Zubsolv, RELISTOR, Azstarys, JOURNAVX, MOVANTIK, ROXYBOND, QULIPTA.
Industry payments across AZ — which companies pay providers there.
